Tag: BioNTech

The company that became a household name during the global health crisis is now executing a deliberate and fundamental strategic ...

A significant regulatory milestone has been achieved by BioNTech in the United States, providing fresh impetus for one of its ...

Shares of BioNTech advanced significantly on Friday following an upgrade from Goldman Sachs. The US investment bank now views the ...

BioNTech is fundamentally realigning its business model, shifting focus from the extraordinary COVID-19 period to a clear strategic emphasis on ...

BioNTech is executing a deliberate strategy to evolve beyond its identity as a COVID-19 vaccine specialist and refocus on its ...

Investors demonstrated notable composure as news broke of a significant patent lawsuit against BioNTech. The German biotech firm, alongside its ...

BioNTech finds itself navigating a dual narrative this week, marked by a significant corporate milestone and the emergence of fresh ...

Investors in Mainz-based biotechnology firm BioNTech are navigating a complex landscape of strategic progress and fresh legal uncertainty. The company ...

Despite a challenging year for its share price, BioNTech concludes 2025 in a stronger strategic and financial position than market ...

The German biotech firm BioNTech is decisively pivoting beyond its pandemic-era identity, placing a substantial strategic bet on mRNA oncology. ...